Seeking Alpha HealthcareOriginal article
Biocryst outlines $690M-$715M 2026 total revenue guidance with operating costs at $420M-$440M
EarningsNeutral
AI Analysis
Summary
BioCryst provided 2026 full-year revenue guidance of $690M-$715M with projected operating costs of $420M-$440M.
Financial Highlights
Revenue
$690M-$715M
Guidance
2026 total revenue guidance of $690M-$715M with operating costs at $420M-$440M
Importance:4/10
Sentiment:
0.00
guidancerevenueoperating_costsfull_year_outlook
Related Companies
Read the original article
Published by Seeking Alpha Healthcare on August 5, 2026 4:03 PM